3beta-Hydroxysteroid dehydrogenase activity in human fetal membranes.
A 3beta-hydroxysteroid dehydrogenase (3betaHSD) was demonstrated in term human fetal membranes (chorion and amnion) with both dehydroepiandrosterone (3beta-hydroxy-5-androsten-17-one) and pregnenolone (3beta-hydroxy-5-pregnen-20-one as substrates, and the subcellular distribution substrate and nucleotide specificity of the enzyme was studied. In both membranes the microsomal fraction (particles which sedimented at 105,000 g after 90 min) had the highest specific activity. The chorion was more active than the amnion but the enzyme in both tissues had similar substrate and nucleotide specificity. NAD was the preferred cofactor, and pregnenolone was a better substrate than dehydroepiandrosterone in the presence of NAD. However, with NADP as cofactor both steroids were equally good substrates. When the 3beta-hydroxysteroid dehydrogenase activity of chorion microsomes was compared with that of placental microsomes, the specific activities were found to be of the same order of magnitude, and the substrate, nucleotide specificity and steroid binding properties were almost identical.
D015096:3-Hydroxysteroid Dehydrogenases / Q000378:metabolism*; D000650:Amnion / Q000201:enzymology*; D002823:Chorion / Q000201:enzymology*; D003687:Dehydroepiandrosterone; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008861:Microsomes / Q000201:enzymology; D009243:NAD / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D010920:Placenta / Q000201:enzymology; D011247:Pregnancy; D011284:Pregnenolone; D013347:Subcellular Fractions / Q000201:enzymology; D013379:Substrate Specificity
D009243:NAD; D003687:Dehydroepiandrosterone; D009249:NADP; D011284:Pregnenolone; D015096:3-Hydroxysteroid Dehydrogenases